Navigation Links
AMICAS Reports Financial Results for the Second Quarter Ended June 30, 2009
Date:8/5/2009

ing of period 7,366 8,536 ------ ------ Cash and cash equivalents at end of period $4,881 $6,353 ====== ====== Supplemental disclosure of cash paid during the period for: Income taxes, net of refunds $- $115 Non-cash investing activities: Unrealized gain (loss) on available-for-sale securities $79 $11 See accompanying Notes to Condensed Consolidated Financial Statements. SUPPLEMENTAL FINANCIAL INFORMATION GAAP TO NON-GAAP RECONCILIATIONS (Unaudited) (in thousands) Three Months Ended Six Months Ended June 30, June 30, -------- -------- 2009 2008 2009 2008 ---- ---- ---- ---- Total revenue $23,493 $13,575 $34,765 $26,363 Acquisition-related revenue adjustments: Maintenance and services 1,934 - 1,934 - Software licenses and system sales 2,073 - 2,073 - ------ ------ ------ ------ Total non-GAAP revenue 27,500 13,575 38,772 26,363 ------ ------ ------ ------ Three Months Ended Six Months Ended June 30, June 30,
'/>"/>
SOURCE AMICAS, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

Related medicine news :

1. The Hospital of Central Connecticut Chooses AMICAS
2. Booth Radiology Extends and Elevates Partnership With AMICAS
3. AMICAS Set to Join Russell 3000 Index
4. AMICAS Showcases Vendor-Neutral Archive Solutions at SIIM 2009
5. AMICAS Schedules First Quarter 2009 Earnings Results Conference Call
6. AMICAS Announces General Availability of AMICAS PACS Version 6.0 at HIMSS 2009
7. AMICAS Announces Completion of Merger with Emageon
8. AMICAS Successfully Completes Tender Offer for Shares of Emageon Inc.
9. Australias Healthinc and AMICAS Announce Exclusive Partnership
10. AMICAS Delivers Advanced Integration Framework to Monroe Clinic
11. AMICAS Reports Financial Results for the Fourth Fiscal Quarter and Year Ended December 31, 2008

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2009)... , WASHINGTON, Nov. 21 /PRNewswire-USNewswire...tatement after the Senate voted to begin full deba...(Logo: http://www.newscom.com/cgi-bin/prnh/200805...er historic step on the road to enacting health in...hurdle, senators will now have an opportunity to d...
(Date:11/21/2009)... , Association Discusses Key Provisions of L...Care Reform ,, ST. CHARLES, Ill., Nov. 21 /PRN...presentatives passing the landmark Affordable Heal...e moving key health reform legislation forward, Co...s broken health care system. Today, AARP hosted a...
(Date:11/21/2009)... HAPPYneuron,s most popular a... the iPhone and iPod Touch. , ...- HAPPYneuron,s most popular and addictive game, S... Touch. Split Words is designed to help banish tha...plitWords iPhone brain game challenges the brain...
(Date:11/20/2009)... , Pioneering Neurologist Closer to Understand...v. 20 Dr. Jeremy Schmah...hool and neurologist at the Massachusetts General ...ented his laboratory,s research on the new field o... MINDlink Foundation. ,, Dr. Schmahmann is an a...
(Date:11/20/2009)... , QUINCY, Mass., Nov. 20 Foll...ermarket Company removed from sale Shedd,s Country...Rice and Shedd,s Country Crock ® Side Dishes ...ite allergen. ,, The following code dates and ...174; Side Dishes DELUXE Cheddar Broccoli Rice 21 o...
Breaking Medicine News(10 mins):Health News:Democratic National Committee Chairman Tim Kaine's Statement on the Senate's Vote to Proceed to Full Floor Debate of Health Insurance Reform Legislation 2Health News:AARP Hosts Rep. Bill Foster In Health Care Reform Forum 2Health News:HAPPYneuron releases iPhone Brain Game 2Health News:HAPPYneuron releases iPhone Brain Game 3Health News:MINDlink Foundation Launches to Connect the Cerebellum to Cures 2Health News:Stop & Shop Alerts Customers to Voluntary Recall by Unilever 2
...e long-term treatment , , MONDAY, Oct. 27 ...trexate are safe and effective for long-term, cont... new research finds. , In a three-year study that...ugs. Etanercept was given as either a 0.4 mg/kg in...
...oup, Inc. (NYSE: HGR ) announces net sales of $17...08, an increase of $16.4 million, or 10.1%,from $1...r. Net income for,the quarter was $7.3 million, an..., or 27.8%, from $0.18 per share in,the third quar...
...ications later, studies find , , MONDAY, O...with rheumatoid arthritis face twice the risk of a...ack tend to have more heart-related complications,...lprit. Diastolic dysfunction impairs the ability o...
...ing the growing number who choose later-in-life pr...ion to the timing of their menopause and infertili... from the University of Michigan have provided new...ay we do business," said MaryFran Sowers, professo...
...etwork, Inc. (http://www.HealthCentral.com ) anno...t of business development for HealthCentral, has b... the company., With a proven track record of grow...nue, and will report to CEO,Christopher M. Schroed...
...ugh personal stories of,North Carolina women and o...ighty percent of,women living with AIDS in North C...g cause of death for African American women ages 2...Living Quilt, (http://www.livingquilt.org ), a web...
Other Medicine News:Health News:Etanercept, Methotrexate Safe for Juvenile RA 2Health News:Hanger Orthopedic Group, Inc. Exceeds Estimates on a 10% Sales Increase and a 28% EPS Increase to $0.23 for the Third Quarter 2008 2Health News:Hanger Orthopedic Group, Inc. Exceeds Estimates on a 10% Sales Increase and a 28% EPS Increase to $0.23 for the Third Quarter 2008 3Health News:Hanger Orthopedic Group, Inc. Exceeds Estimates on a 10% Sales Increase and a 28% EPS Increase to $0.23 for the Third Quarter 2008 4Health News:Hanger Orthopedic Group, Inc. Exceeds Estimates on a 10% Sales Increase and a 28% EPS Increase to $0.23 for the Third Quarter 2008 5Health News:Hanger Orthopedic Group, Inc. Exceeds Estimates on a 10% Sales Increase and a 28% EPS Increase to $0.23 for the Third Quarter 2008 6Health News:Hanger Orthopedic Group, Inc. Exceeds Estimates on a 10% Sales Increase and a 28% EPS Increase to $0.23 for the Third Quarter 2008 7Health News:Hanger Orthopedic Group, Inc. Exceeds Estimates on a 10% Sales Increase and a 28% EPS Increase to $0.23 for the Third Quarter 2008 8Health News:Hanger Orthopedic Group, Inc. Exceeds Estimates on a 10% Sales Increase and a 28% EPS Increase to $0.23 for the Third Quarter 2008 9Health News:Rheumatoid Arthritis a Threat to the Heart 2Health News:Rheumatoid Arthritis a Threat to the Heart 3Health News:Rheumatoid Arthritis a Threat to the Heart 4Health News:New hormone data can predict menopause within a year 2Health News:The HealthCentral Network Names Jeremy Shane President and Chief Operating Officer 2Health News:The HealthCentral Network Names Jeremy Shane President and Chief Operating Officer 3Health News:Southern AIDS Living Quilt Project in Raleigh Tomorrow 2
(Date:11/20/2009).... 20 Smith & Nephew ...o announce the signing of a technology development...ense that may lead to the creation of a fracture f...ment of the limbs of soldiers who sustain battlefi...d Research Projects Agency (DARPA), the central re...
(Date:11/19/2009)...ov. 19 In a series of ne..., Heska Corporation (Nasdaq: HSKA ) ("Heska" or t...w and improved website. The upgraded site is the ...rogramming to align the site with the company,s ne...go: http://www.newscom.com/cgi-bin/prnh/20000622...
(Date:11/19/2009)...Nov. 19 Ligon Discovery, Inc., whi...nology to find drugs against high-value targets, t...ncing led by incTANK Ventures. The company will us...mpaign that will screen over 100 high-value diseas...entures General Partner Christian Bailey joins the...
Breaking Medicine Technology:Smith & Nephew Orthopaedics Selected to Develop New Technology for Treating Battlefield Injuries 2Smith & Nephew Orthopaedics Selected to Develop New Technology for Treating Battlefield Injuries 3Smith & Nephew Orthopaedics Selected to Develop New Technology for Treating Battlefield Injuries 4Heska Announces Launch of New Website 2Heska Announces Launch of New Website 3Cambridge-based Ligon Discovery Raises $1M in Seed Funding 2Cambridge-based Ligon Discovery Raises $1M in Seed Funding 3MHPA Leading Association Representing Medicaid Health Plans Issues Statement on Proposed California SCHIP Elimination 47534 1MHPA Leading Association Representing Medicaid Health Plans Issues Statement on Proposed California SCHIP Elimination 47534 2Quest Diagnostics Introduces First Comprehensive Laboratory Test To Analyze KRAS NRAS and BRAF Gene Mutations in Reflex Testing Service 47531 1Quest Diagnostics Introduces First Comprehensive Laboratory Test To Analyze KRAS NRAS and BRAF Gene Mutations in Reflex Testing Service 47531 2Quest Diagnostics Introduces First Comprehensive Laboratory Test To Analyze KRAS NRAS and BRAF Gene Mutations in Reflex Testing Service 47531 3Quest Diagnostics Introduces First Comprehensive Laboratory Test To Analyze KRAS NRAS and BRAF Gene Mutations in Reflex Testing Service 47531 4Quest Diagnostics Introduces First Comprehensive Laboratory Test To Analyze KRAS NRAS and BRAF Gene Mutations in Reflex Testing Service 47531 5Pixantrone Significantly Increases Complete Remissions Overall Response Rates Frequency of Durable Remissions and Progression Free Survival in Patie 12396 1Pixantrone Significantly Increases Complete Remissions Overall Response Rates Frequency of Durable Remissions and Progression Free Survival in Patie 12396 2Pixantrone Significantly Increases Complete Remissions Overall Response Rates Frequency of Durable Remissions and Progression Free Survival in Patie 12396 3Pixantrone Significantly Increases Complete Remissions Overall Response Rates Frequency of Durable Remissions and Progression Free Survival in Patie 12396 4Pixantrone Significantly Increases Complete Remissions Overall Response Rates Frequency of Durable Remissions and Progression Free Survival in Patie 12396 5
...l Incorporated,(Nasdaq: VICL ) today announced th...rial of the company,s Vaxfectin(TM)-formulated pla...uble-blind, placebo-controlled trial will,evaluate...o 60 healthy,volunteers age 18 to 45 at two U.S. c...emic influenza vaccine and,demonstrated its effect...
...ies Set To Begin By Early 2008, WOODRIDGE, Ill., ...sdaq: ADLS ) today announced that the United,Stat...Orphan Drug,Designation to its oncology product, A...lanoma. Melanoma is estimated to be the sixth most...ited States and accounts for,about 4% of all skin ...
Other Medicine Technology:Vical Begins Phase 1 Trial of DNA Vaccine Against H5N1 Pandemic Influenza 2Vical Begins Phase 1 Trial of DNA Vaccine Against H5N1 Pandemic Influenza 3Vical Begins Phase 1 Trial of DNA Vaccine Against H5N1 Pandemic Influenza 4Advanced Life Sciences Announces ALS-357 Granted FDA Orphan Drug Designation for Metastatic Melanoma 2Advanced Life Sciences Announces ALS-357 Granted FDA Orphan Drug Designation for Metastatic Melanoma 3Advanced Life Sciences Announces ALS-357 Granted FDA Orphan Drug Designation for Metastatic Melanoma 4
Salmonella Typhi Antigen - Rapid Test
IntraStent DoubleStrut
hCG Urine Cassette 5mm - Rapid Test
hCG Combo Urine/Serum - Rapid Test
Medicine Products: